Inflammatory Metabolite Index Predicts Ischemic Stroke Risk in Women

Ischemic stroke accounts for the vast majority of cerebrovascular events and is a leading cause of long-term disability, with women facing a higher lifetime risk and worse functional outcomes than men [1, 2]. While traditional risk factors are well-defined, systemic inflammation is increasingly recognized as a key contributor to atherosclerotic disease [3]. However, standard inflammatory biomarkers like C-reactive protein often lack the specificity to capture the complex metabolic dysregulation that precedes a clinical event [4]. Advances in metabolomics, the large-scale study of small molecule metabolites, now permit a more granular view of the pathways linking chronic inflammation to vascular occlusion [5]. A new study offers insight into how a specific metabolic profile may help identify women at elevated risk for ischemic stroke, independent of conventional risk factors.